Possible involvement of receptors in the pathogenesis of schizophrenia has been suggested. In this study we searched systematically for polymorphisms in the 5-franking region of the 1 receptor. Genetic variation in this region could reduce the expression of the gene, and this suggestion is compatibl
Association study of a polymorphism of nonerythroid ?-spectrin gene with schizophrenia
โ Scribed by Murakami, Naoya; Kitamura, Noboru; Kajimoto, Yasuo; Hashimoto, Takeshi; Yasuda, Minoru; Maeda, Kiyoshi; Sakai, Norio; Shirakawa, Osamu; Nishino, Naoki; Tanaka, Chikako; Saito, Naoaki
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 7 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0148-7299
- DOI
- 10.1002/(sici)1096-8628(19990820)88:4<291::aid-ajmg1>3.0.co;2-n
No coin nor oath required. For personal study only.
โฆ Synopsis
The specificity of cytoarchitectural abnormalities in limbic structures of patients with schizophrenia and their contributions towards the etiology of schizophrenia remain unknown. We have recently reported an increased breakdown of nonerythroid โฃ-spectrin (fodrin), a major component of neuronal cytoskeletal proteins, in schizophrenic left superior temporal cortices [Kitamura et al., 1998: Biol Psychiatry 43: 254-262], suggesting that polymorphisms of the โฃ-spectrin gene might contribute to the vulnerability to schizophrenia. We screened for genetic variations associated with schizophrenia through the C-terminus sequences of the human nonerythroid โฃ-spectrin gene (SPTAN1) spanning two EF-hands and also tested a possible contribution of the polymorphism to the development of schizophrenia by an association study. We found a polymorphic region of an intron located in the second EF-hand of SPTAN1 gene. There was no significant difference between patients with schizophrenia and controls in allele frequencies or genotype distribution. There is evidence that the Psh BI SPTAN1 gene polymorphism does not play a major role in the genetic component of schizophrenia.
๐ SIMILAR VOLUMES
The cholecystokinin A receptor (CCK-AR) modulates CCK-stimulated dopamine release in the posterior nucleus accumbens, and its gene is mapped to 4p15.2-15.1 with the dopamine receptor 5 (DR5) gene. We speculated that alterations in the CCK-AR lead to an increase in dopamine release, which may in turn
A putative association of schizophrenia with a Msc I restriction fragment length polymorphism at the dopamine D3 receptor gene locus (DRD3) was tested among Indian families, using haplotype relative risk analysis and the transmission disequilibrium test (n=66 families and 58 sets of transmissions, r
Serotonergic (5-hydroxytryptamine; 5-HT) transmission may play an important role in the treatment and/or pathogenesis of schizophrenia. Previous studies reported that several atypical antipsychotic agents have high affinities for the 5-HT 6 receptor. The 5-HT 6 receptor gene polymorphism might contr
Recent genetic analyses have suggested a linkage between schizophrenia and the chromosomal region 22q12-q13. 14-3-3 protein, abundant in the brain, mediates interactions between diverse molecules of biological activities; its gene was recently mapped to chromosome 22q12.1-q13.1. We therefore investi
As part of the European Multicentre Association Study of Schizophrenia (EMASS), we studied polymorphisms in the dopamine DRD2 and DRD3 receptor genes. The EMASS collaboration was established to create a large, statistically powerful sample of schizophrenic patients and controls from different Europe